OJO SECO / EEUU . Grifols Alcanzo un Acuerdo de Colaboración con Selagine Para Tratar el Ojo Seco . Ambas Compañías Desarrollarán Colirios de Inmunoglobulinas / ... / Las 50 BIOFARMACEUTICAS MEJOR POSICIONADAS Y SUS PRODUCTOS EN I+D PARA EL TRATAMIENTO DEL OJO SECO .

 

Selagine Enters into a Collaborative Agreement with Grifols for Development and Commercialization of Immunoglobulin Eye Drops for Treating Dry Eye Disease .

---

NEWS PROVIDED BY

Selagine, Inc 

---

CHICAGO, /PRNewswire/ -- Selagine, Inc., a Spin-Out Company From the University of Illinois at Chicago (UIC), Announced Today that it has Entered into a Research, Development And Sublicense Agreement With Grifols (Nasdaq: GRFS), a Global Leader in Plasma-derived Medicines, For The Development and Commercialization of Immunoglobulin Eye Drops for Dry Eye Disease ...

******************

*************

********

****